Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J. Hope

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Frontiers in Immunology|January 10, 2022
Development of an <i>In Vivo</i> Probe to Track SARS-CoV-2 Infection in Rhesus MacaquesPatrick J Madden, Muhammad S Arif, Mark E Becker, et al.
Science Translational Medicine|August 19, 2021
Blocking α<sub>4</sub>β<sub>7</sub> integrin delays viral rebound in SHIV<sub>SF162P3</sub>-infected macaques treated with anti-HIV broadly neutralizing antibodiesInes Frank, Mariasole Cigoli, Muhammad S Arif, et al.
Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.
Plos Pathogens|May 31, 2023
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall responseLaTonya D Williams, Xiaoying Shen, Sheetal S Sawant, et al.
Mucosal Immunology|October 18, 2019
Impact of chemokine C-C ligand 27, foreskin anatomy and sexually transmitted infections on HIV-1 target cell availability in adolescent South African malesClive M Gray, Kyle L O'Hagan, Ramon Lorenzo-Redondo, et al.
Nature Communications|March 29, 2017
A microfluidic culture model of the human reproductive tract and 28-day menstrual cycleShuo Xiao, Jonathan R Coppeta, Hunter B Rogers, et al.
Immunity|May 18, 2017
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding LoopEvan M Cale, Jason Gorman, Nathan A Radakovich, et al.
Nature Medicine|September 8, 2020
Recommendations for measuring HIV reservoir size in cure-directed clinical trialsMohamed Abdel-Mohsen, Douglas Richman, Robert F Siliciano, et al.
Molecular Cell|April 30, 2021
Functional landscape of SARS-CoV-2 cellular restrictionLaura Martin-Sancho, Mary K Lewinski, Lars Pache, et al.
Nature Communications|January 21, 2022
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2Lamiaa El-Shennawy, Andrew D Hoffmann, Nurmaa Khund Dashzeveg, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Frontiers in Immunology|January 10, 2022
Development of an <i>In Vivo</i> Probe to Track SARS-CoV-2 Infection in Rhesus MacaquesPatrick J Madden, Muhammad S Arif, Mark E Becker, et al.
Science Translational Medicine|August 19, 2021
Blocking α<sub>4</sub>β<sub>7</sub> integrin delays viral rebound in SHIV<sub>SF162P3</sub>-infected macaques treated with anti-HIV broadly neutralizing antibodiesInes Frank, Mariasole Cigoli, Muhammad S Arif, et al.
Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.
Plos Pathogens|May 31, 2023
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall responseLaTonya D Williams, Xiaoying Shen, Sheetal S Sawant, et al.
Mucosal Immunology|October 18, 2019
Impact of chemokine C-C ligand 27, foreskin anatomy and sexually transmitted infections on HIV-1 target cell availability in adolescent South African malesClive M Gray, Kyle L O'Hagan, Ramon Lorenzo-Redondo, et al.
Nature Communications|March 29, 2017
A microfluidic culture model of the human reproductive tract and 28-day menstrual cycleShuo Xiao, Jonathan R Coppeta, Hunter B Rogers, et al.
Immunity|May 18, 2017
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding LoopEvan M Cale, Jason Gorman, Nathan A Radakovich, et al.
Nature Medicine|September 8, 2020
Recommendations for measuring HIV reservoir size in cure-directed clinical trialsMohamed Abdel-Mohsen, Douglas Richman, Robert F Siliciano, et al.
Molecular Cell|April 30, 2021
Functional landscape of SARS-CoV-2 cellular restrictionLaura Martin-Sancho, Mary K Lewinski, Lars Pache, et al.
Nature Communications|January 21, 2022
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2Lamiaa El-Shennawy, Andrew D Hoffmann, Nurmaa Khund Dashzeveg, et al.
Pageof 17